Clinical Trials | June 15, 2024
Sun Pharma and Moebius Medical present Phase 2b study on MM-II
There is an urgent need for more therapeutic treatment options for patients with painful osteoarthritis
There is an urgent need for more therapeutic treatment options for patients with painful osteoarthritis
Nadda expressed his concern about growing incidence of Non-Communicable Diseases and the importance of awareness regarding healthy diet and lifestyle
Fischer MVL envisages to offer a diverse portfolio of diagnostic solutions
As on 31st March 2024, Jubilant Pharmova Limited reported Gross Debt at Rs. 3,414 crore
Approval based on results from T2NOW, one of the largest paediatric type-2 diabetes Phase III trials to date
Azilsartan Medoxomil and Chlorthalidone Tablets had annual sales of US$ 77.9 mn in the United States (IQVIA MAT March 24).
Private financing round supported by Fidelity Management & Research Company, T. Rowe Price and Durable Capital Partners
There was no observation related to data integrity reported
Accelerating sustainability in Indian pharma industry
The new brand identity embodies Neuland's unwavering commitment to innovation, integrity, collaboration, and progress
Subscribe To Our Newsletter & Stay Updated
